The Washington Times

Nightline

Latest Nightline Items
  • FILE - In this Jan. 21, 2006 file photo, David Westin, President of ABC News talks about the network's redesigned evening news broadcast at the ABC 2006 Winter Press Tour, in Pasadena, Calif. Westin said in a memo to his staff on Monday, Sept. 6, 2010 that he is stepping down at the end of the year after more than 13 years on the job. (AP Photo/Rene Macura, File)

    ABC News president David Westin steps down

    ABC News President David Westin, the longest-reigning network news division chief, with more than 13 tumultuous years on the job, told his staff Monday that he is resigning and will leave by the end of the year.


  • ABC News president David Westin steps down

    ABC News President David Westin, the longest-reigning network news division chief, with more than 13 tumultuous years on the job, told his staff Monday that he is resigning and will leave by the end of the year.


  • FILE - In this undated publicity released by ABC-TV, Martin Bashir, co-anchor of "Nightline," Martin Bashir is shown. (AP Photo/ABC, DONNA SVENNEVIK, file)

    Martin Bashir leaving ABC's 'Nightline' for NBC

    ABC News' Martin Bashir is leaving his post at "Nightline" to be an anchor for MSNBC and a contributor to "Dateline NBC," the network announced Thursday.


  • In this photo released by CBS, U.S. World Cup soccer team midfielder Landon Donovan, left, talks with host David Letterman on the set of the "Late Show with David Letterman," Tuesday, June 29, 2010, in New York. (AP Photo/CBS, Heather Wines)

    Viewership of late-night talk shows sinks

    Late-night ratings sank over the past three months, despite the attention and extraordinary television created over the winter by the drama of Mr. Leno taking back "The Tonight Show" from Conan O'Brien.


  • Fewer people are watching late-night talk shows

    Jay Leno and David Letterman are in the twilight of their days as late-night TV kings, and it's not clear that any late-night comic will wield that kind of broad influence again.


  • Drug-safety 'advocates'

    Earlier this week, a joint session of two Food and Drug Administration advisory committees recommended that Avandia, one of two drugs that reduce insulin resistance, stay on the market with added information about which patients should avoid taking the medicine in order to reduce the risk of heart attacks. The recommendation, based on a careful evaluation of a massive amount of data, focused on whether it was possible to tailor the use of Avandia, which has helped people with diabetes stave off blindness, leg amputations and kidney failure, to groups of patients that might be a higher risk for heart problems.


  • Drug-safety 'advocates'

    Earlier this week, a joint session of two Food and Drug Administration advisory committees recommended that Avandia, one of two drugs that reduce insulin resistance, stay on the market with added information about which patients should avoid taking the medicine in order to reduce the risk of heart attacks. The recommendation, based on a careful evaluation of a massive amount of data, focused on whether it was possible to tailor the use of Avandia, which has helped people with diabetes stave off blindness, leg amputations and kidney failure, to groups of patients that might be a higher risk for heart problems.


Happening Now